Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis

• Philipp A. Reuken ,

  * E-mail: philipp.reuken@med.uni-jena.de

  Affiliation Department of Internal Medicine IV (Gastroenterology, Hepatology, and Infectious Diseases), Jena University Hospital, Jena, Germany

  ⨯
• Dorian Torres,

  Affiliation Department of Internal Medicine IV (Gastroenterology, Hepatology, and Infectious Diseases), Jena University Hospital, Jena, Germany

  ⨯
• Michael Baier,

  Affiliation Division of Infectious Diseases and Tropical Medicine, Department of Gastroenterology and Rheumatology, Leipzig University Hospital, Leipzig, Germany

  ⨯
• Bettina Löffler,

  Affiliation Division of Infectious Diseases and Tropical Medicine, Department of Gastroenterology and Rheumatology, Leipzig University Hospital, Leipzig, Germany

  ⨯
• Christoph Lübbert,

  Affiliation Institute of Medical Microbiology, Jena University Hospital, Jena, Germany

  ⨯
• Norman Lippmann,

  Affiliation Institute for Medical Microbiology and Epidemiology of Infectious Diseases, Leipzig University Hospital, Leipzig, Germany

  ⨯
• Andreas Stallmach,

  Affiliations Department of Internal Medicine IV (Gastroenterology, Hepatology, and Infectious Diseases), Jena University Hospital, Jena, Germany, The Integrated Research and Treatment Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany

  ⨯
• Tony Bruns

  Affiliations Department of Internal Medicine IV (Gastroenterology, Hepatology, and Infectious Diseases), Jena University Hospital, Jena, Germany, The Integrated Research and Treatment Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany

  ⨯